Faculty

February 21, 2009

San Antonio, TX

Chandra P. Belani, MD,

Miriam Beckner Professor of Medicine, Penn State Milton S. Hershey Medical Center, Penn State College of Medicine, Deputy Director, Penn State Cancer Institute, Hershey, PA

Robert Benjamin, MD ,

Professor of Medicine, MD Anderson Cancer Center, Houston, TX

Jeffrey Crawford, MD ,

Professor of Medicine, Duke University Medical Center, Durham , NC

David Ilson, MD ,

Professor of Internal Medicine, Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY

Mark Petrylak, MD,

Associate Professor, Division of Medical Oncology, Columbia Presbyterian Medical Center, New York, NY

Michael Keating, MD,

Professor of Medical Oncology/Hematology, MD Anderson Cancer Center, Houston, TX

John G. Kuhn, Pharm. D,

Professor, UT College of Pharmacy and Clinical Professor, UT Health Science Center at San Antonio, Department of Medicine, Acting Medical Research Director, South Texas Oncology/Hematology, San Antonio, TX

Howard McLeod, Pharm.D,

Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina, Chapel Hill, NC

Mark Pegram, MD,

Professor of Medical Oncology, Mt. Sinai Cancer Center, Miami, FL

David Reardon, MD,

Professor of Medicine, Duke University Medical Center, Duke Brain Tumor Program, Durham, NC

J. Tate Thigpen, MD,

Professor of Medicine and Director, Division of Medical Oncology, University of Mississippi Medical Center, Jackson, MS

Anthony Tolcher, MD,

Director of Clinical Research, South Texas Accelerated Research Therapeutics (START), San Antonio, TX